Addressing the quality of the ESMO-MCBS
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/28/6/1406/17646313/mdx077.pdf
Reference6 articles.
1. A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS);Cherny;Ann Oncol,2015
2. Do contemporary randomized controlled trials meet ESMO thresholds for meaningful clinical benefit?;Del Paggio;Ann Oncol,2017
3. Quality of life as a primary end point in oncology;Roila;Ann Oncol,2001
4. Lapatinib combined with letrozole versus letrozole and placebo as first-line therapy for postmenopausal hormone receptor-positive metastatic breast cancer;Johnston;J Clin Oncol,2009
5. Quality of life in hormone receptor-positive HER-2+ metastatic breast cancer patients during treatment with letrozole alone or in combination with lapatinib;Sherrill;Oncologist,2010
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Initial and supplementary indication approval of new targeted cancer drugs by the FDA, EMA, Health Canada, and TGA;Investigational New Drugs;2022-04-07
2. Experiences with Prescribing Large Quantities of Systemic Anticancer Therapy Near Death;Journal of Palliative Medicine;2019-12-01
3. Patient-Centered Cancer Drug Development: Clinical Trials, Regulatory Approval, and Value Assessment;American Society of Clinical Oncology Educational Book;2019-05
4. Re-aligning the ASCO and ESMO clinical benefit frameworks for modern cancer therapies;Annals of Oncology;2018-03
5. Five years of EMA-approved systemic cancer therapies for solid tumours—a comparison of two thresholds for meaningful clinical benefit;European Journal of Cancer;2017-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3